Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Alejandro D Bendala-Estrada"'
Autor:
Jorge Calderón-Parra, Antonio Muiño-Miguez, Alejandro D Bendala-Estrada, Antonio Ramos-Martínez, Elena Muñez-Rubio, Eduardo Fernández Carracedo, Javier Tejada Montes, Manuel Rubio-Rivas, Francisco Arnalich-Fernandez, Jose Luis Beato Pérez, Jose Miguel García Bruñén, Esther Del Corral Beamonte, Paula Maria Pesqueira Fontan, Maria Del Mar Carmona, Rosa Fernández-Madera Martínez, Andrés González García, Cristina Salazar Mosteiro, Carlota Tuñón de Almeida, Julio González Moraleja, Francesco Deodati, María Dolores Martín Escalante, María Luisa Asensio Tomás, Ricardo Gómez Huelgas, José Manuel Casas Rojo, Jesús Millán Núñez-Cortés, SEMI-COVID-19 Network
Publikováno v:
PLoS ONE, Vol 16, Iss 5, p e0251340 (2021)
BackgroundMost patients with COVID-19 receive antibiotics despite the fact that bacterial co-infections are rare. This can lead to increased complications, including antibacterial resistance. We aim to analyze risk factors for inappropriate antibioti
Externí odkaz:
https://doaj.org/article/6d2d00c709194c5bb3216f8ea9c77376
Autor:
Alejandro D. Bendala‐Estrada, Mariana Diaz‐Almiron, Carmen Busca, Rafael Mican, Julen Cadiñanos, Maria Luisa Montes, Luz Martin‐Carbonero, Eulalia Valencia, Rocío Montejano, Ana Delgado‐Hierro, Jose I. Bernardino
Publikováno v:
HIV medicineREFERENCES.
The use of tenofovir alafenamide (TAF) has been associated with increased cholesterol and body weight. Real-life data on the metabolic effects of switching from a TAF-based triple regimen to a dolutegravir (DTG)-based two-drug regimen (2-DR) are scar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a82561a08a0ffed02e789905f0dac4bb
https://pubmed.ncbi.nlm.nih.gov/36394195
https://pubmed.ncbi.nlm.nih.gov/36394195